DSpace
Tokyo Dental College | Library

IRUCAA@TDC >
010 雑誌掲載論文 = Journal Articles >
010 論文 = Journal Articles >

Please use this identifier to cite or link to this item:
http://hdl.handle.net/10130/5845
   
Google™ Scholar
Cited By - Related - Other Copies

Files in This Item:

File Description SizeFormat
s13023-021-02033-7.pdf1.2 MBAdobe PDFDownload
Title: Novel alterations in IFT172 and KIFAP3 may induce basal cell carcinoma
Authors: Onodera, S
Morita, N
Nakamura, Y
Takahashi, S
Hashimoto, K
Nomura, T
Katakura, A
Kosaki, K
Azuma, T
Others: 生化学
口腔病態外科学
市病・口腔腫瘍外科学
市病・オーラルメディシン・病院歯科学
市病・皮膚科
市病・臨床検査科
Publisher: BioMed Central
ISSN: 1750-1172
DOI: https://doi.org/10.1186/s13023-021-02033-7
PMID: http://www.ncbi.nlm.nih.gov/pubmed/34674729
URI: http://hdl.handle.net/10130/5845
Journal Title: Orphanet journal of rare diseases
Date of Issued: 2021-10
Volume: 16
Article Number: 443
Copy Right: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Appears in Collections:010 論文 = Journal Articles

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.